Dr. Joe Cao Truong

DMD | Dentist



  
  9437 Holy Cross Lane, Breese
  Illinois, 62230

  618-526-4233    618-526-4908 Maps & Directions
Dr. Joe Cao Truong is a Breese, Illinois based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 9437 Holy Cross Lane, Breese. Patients can reach him at 618-526-4233.
Dr. Joe Cao Truong is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Joe Cao Truong speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Joe Cao Truong
Specialization: Dentist
Gender:Male
Credentials: DMD
Accepts Medicare Assignment:May Accept
Practice Address:9437 Holy Cross Lane, Breese,
Illinois, 62230
Phone:618-526-4233
Fax:618-526-4908
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 8022317528
Enrollment ID: I20160505000412
NPI Number: 1144328832
NPI Enumeration Date: 20 Sep, 2006
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 9437 Holy Cross Lane,
Breese, Illinois
Zip: 62230
Phone Number: 618-526-4233
Fax Number: 618-526-4908
Patients can reach Dr. Joe Cao Truong at 9437 Holy Cross Lane, Breese, Illinois or can call to book an appointment on 618-526-4233. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.

Comments/ Reviews: